Ennov
Ennov provides regulatory, quality, clinical, and pharmacovigilance software solutions for life sciences and other regulated industries, offering a unified platform to manage compliance, content, and data across the product lifecycle. Its products help pharmaceutical, biotech, medical device, and related organizations digitize and streamline processes such as submissions, safety reporting, quality management, and clinical trial documentation. The company generates revenue through licensing and subscriptions to its software suite, along with related implementation and support services.
- Industry-Specific ERP
- IT Consulting & Implementation
- Revenue
- $45.0M
- Employees
- 250
- Founded
- 1999
- Headquarters
- Paris, France
What 37 Arbolus experts think of Ennov
NPS responses are generally positive, with most ratings in the 7–9 range and only a minority below 6. 60% of experts show intent to renew or maintain spend, though some, particularly Influencers, remain 'not sure' or decline intent. Customers are predominantly at the More Than 1 Year implementation stage, correlating to increased satisfaction and higher spend brackets. Key themes include praise for cost-effectiveness, robust compliance, and unified architecture but note requests for deeper AI, streamlined integration, and improvement in user experience. Overall Customer Sentiment: Positive
Who reviewed Ennov
- C-Suite 57% (21)
- Director 30% (11)
- Manager 14% (5)
Employer names and spend open in the full report, along with the other 34 customers.
Everything 37 customers told us about Ennov.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
-5 Net Promoter Score, from 37 scored reviews- Promoters 7
- Passives 21
- Detractors 9
Cumulative NPS by month
+0 over 6 months- Mar 7
- Apr 7
- May 7
- Jun 7
- Aug 7
- Sep 7
Net Promoter Score across 6 reviews, accumulated up to each month. Category median 25 across 6 companies.
Praised
- Regulatory Specialization and Workflow Depth
- On-Premise Deployment Option
- Unified Compliance and Cost Effectiveness
- Broader End-to-End Clinical Offering
Criticised
- Customer Care and AI Improvement
- AI and User Experience Limitations
- Integration and Customization Complexity
- Switching Risk from Delayed Innovation
What customers say
Renewal intent
Plan to renew 52%Plan to renew, by seniority
- 44% 16 answers
- 67% 6 answers
- 67% 3 answers
- 8.1/10 Average score from customers who will renew
- 6.9/10 Average score from undecided customers
- 4.5/10 Average score from customers not renewing
Top alternatives
Most weighed by Ennov customers
Report
More in ERP Software and Security & Compliance
Other companies in both categories with a customer report.
For people who use Ennov
Do you use Ennov at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 37 customers of Ennov have already contributed
Takes a few minutes. Your identity stays anonymous.